• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Genzyme

Genzyme

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme ’s Lemtrada in Pivotal Studies

    At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme ’s Lemtrada in Pivotal Studies

  2. FDA Approves Genzyme ’s Cerdelga™ (eliglustat) Capsules

    FDA Approves Genzyme ’s Cerdelga™ (eliglustat) Capsules

  3. Sanofi: Study Shows Positive Results from Lemtrada Tests

    Sanofi: Study Shows Positive Results from Lemtrada Tests

  4. FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease

    FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease

  5. Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

    Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

  6. Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

    Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

  7. Sanofi Gets U.S. FDA Approval for Gaucher Disease Treatment

    Sanofi Gets U.S. FDA Approval for Gaucher Disease Treatment

  8. REITs, Target Dates, Dollar-Proofing, and More

    A roundup of investment news.

  9. High-Confidence Stock Picks

    Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.